@article{article, title  = {{The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer}},

 url = {{https://eprints.whiterose.ac.uk/107775/ }},

 year = {{2012}},

 month = {{12}},

 author = {{Collinson FJ and Gregory WM and McCabe C and Howard H and Lowe C and Potrata D and Tubeuf S and Hanlon P and McParland L and Wah T and Selby PJ et al}},

 doi = {{10.1186/1471-2407-12-598}},

 volume = {{12}},

 journal = {{BMC CANCER}},

 note = {{Accessed on 2024/12/27}}}